Aimei Health Technology Co., Ltd
AFJK
$10.95
$0.000.00%
| Weiss Ratings | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | C- | |||
| Rating Factors | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Fair | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.09% | |||
| 30-Day Total Return | 1.96% | |||
| 60-Day Total Return | 3.11% | |||
| 90-Day Total Return | 3.50% | |||
| Year to Date Total Return | 2.05% | |||
| 1-Year Total Return | 7.56% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -0.45% | |||
| 52-Week Low % Change | 7.56% | |||
| Price | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.00 | |||
| 52-Week Low Price | $10.18 | |||
| 52-Week Low Price (Date) | Mar 14, 2024 | |||
| 52-Week High Price (Date) | Feb 18, 2025 | |||
| Valuation | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 98.83M | |||
| Enterprise Value | 98.73M | |||
| Price/Earnings (TTM) | 38.57 | |||
| Earnings Per Share (TTM) | 0.28 | |||
| Earnings Per Share Growth | -9,889.66% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -124.01 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $10.95 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -139.96 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 9.03M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212 845 9945 | |||
| Address | 10 East 53rd Street New York, NY 10022 | |||
| Website | -- | |||
| Country | United States | |||
| Year Founded | 2023 | |||
| Profitability | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -705.40K | |||
| Net Income (TTM) | 2.37M | |||
| Net Income Avl. to Common (TTM) | 2.37M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -- | |||
| EPS Diluted (TTM) | 0.28 | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 103.60K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 123.90K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -796.90K | |||
| Current Ratio (Q) | 0.537 | |||
| Book Value Per Share (Q) | -$0.09 | |||
| Total Assets (Q) | 72.78M | |||
| Total Current Liabilities (Q) | 230.80K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 73.58M | |||
| Total Common Equity (Q) | -796.90K | |||
| Cash Flow | AFJK - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -104.54M | |||
| Cash from Financing (TTM) | 105.40M | |||
| Net Change in Cash (TTM) | 384.00K | |||
| Levered Free Cash Flow (TTM) | -228.60K | |||
| Cash from Operations (TTM) | -477.10K | |||
